The Philips Azurion interventional imaging system was recently updated with new ultralow dose technology that is said to reduce X-ray exposure by up to 50% during coronary procedures.
Experts are interested in using computed tomography as an investigative tool due to its ability to provide detailed information while also preserving historical artifacts.
It can be difficult to deliver targeted therapy to the brain due to its protective barrier, which only allows certain nutrients and oxygen to pass through.
Experts hope the information gained from their research could help providers better determine whether patients will regain mobility after sustaining an injury.
These findings present additional evidence that invasive imaging tests are not necessarily more effective when it comes to evaluating patients for chest pain.